This ADC product is comprised of an anti-C-kit monoclonal antibody (9P3) conjugated via a CX1-1 linker to DM1. The DM1 is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell,
* VAT and and shipping costs not included. Errors and price changes excepted